Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Davi Pharmaceutical is a Chinese pharmaceutical manufacturer focused on active pharmaceutical ingredients and related pharmaceutical production services. The company was founded in 2004 and operates from Huzhou, Zhejiang, with GMP-certified manufacturing capabilities and a stated focus on methotrexate, calcium folinate (leucovorin calcium), and calcium levofolinate. Public directory and company-registry sources indicate that it is an active, foreign-funded manufacturer serving domestic and export markets rather than a drug-discovery biotech with a disclosed clinical pipeline. Its business appears centered on commercial production, quality-compliant manufacturing, and sales of APIs and selected pharmaceutical products. The company also appears to have experience in commissioned pharmaceutical manufacturing and drug import/export activities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Davi Pharmaceutical.